
Introduction of Fortune Pharmacal Company Limited
Founded in 1954, Fortune Pharmacal adheres to the belief to "always go one step further" for you. We have accompanied the growth of Hong Kong people, enduring the ups and downs of more than half a century. We focus on the research and development and manufacturing of over-the-counter medication (OTC products), actively expand factories, innovate pharmaceutical formulation, optimize manufacturing systems, and strive to protect everyone's health and promote the vitality of Hong Kong. As Fortune Pharmacal is always going one step further, we take the lead in investing resources in environmental, social, and corporate governance (ESG) projects. Our goal is to contribute to the sustainable development of the health of Hong Kong people and the world's ecology, culminating in the lasting legacy of good fortune.
Fortune Pharmacal’s cold, cough and flu series, Coltalin, has firmly positioned itself as the leader in cold and flu medicine sales in Hong Kong since 19811. In addition to best-selling Coltalin adult tablets and children's chewable tablets, Fortune Pharmacal has also developed a diversified range of over-the-counter medicines to meet the needs of different customers. The ongoing objective is to expand our product offering to cover all age groups and develop health care solutions for infants up to the elderly, and medicines for chronically ill patients to improve their health and promote high-quality lifestyles.
Fortune Pharmacal’s concept of health is not limited to just physical and mental health, but also broader environmental and social health. Fortune Pharmacal adheres to its corporate responsibilities and creates a win-win environment with every relevant stakeholder, including customers, partners, employees, and shareholders. We strive to incorporate sustainable development into the company's mission and are committed to having a positive impact on both society and the environment. We take important measures to advocate environmental responsibility through such initiatives as formulating carbon emission reduction controls and improving the environmental awareness of employees, the industry, and the general public. Our objective is to involve everyone to create a future of good fortune.
Fortune Pharmacal has always attached great importance to the quality and efficacy of our products. The design of the manufacturing plant comprises a high-standard closed system that reduces the risk of cross-contamination during manufacturing, and conducts real-time monitoring and quality control. Each batch of medicine is thoroughly tested before distribution to ensure its safety, effectiveness, and quality. The entire manufacturing process of each Fortune tablet must comply with the PIC/S GMP standard of the Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme, one of the most stringent GMP standards, and follow strict corporate SOP (standard operating procedures) as part of important operational and management guidelines.
Fortune Pharmacal utilizes Industry 4.0 Smart Manufacturing which integrates existing resources, processes, and operational data towards extensive big data analyses. We incorporate artificial intelligence systems to predict and assess future manufacturing capacities to meet forecasted demand. We are able to make timely and automatic adjustments to supplies to create extremely efficient operations. The enhanced visibility and improved decision making processes allow us to react and adapt quickly which leads to precise production levels, waste reduction, and better product quality. This raises our competitiveness significantly and contributes to the sustainable development of the business.
More than 60% of greenhouse gas emissions in Hong Kong result from power generation. Fortune Pharmacal takes the initiative to introduce and utilize renewable energy alternatives. We boast the largest solar power generation system in Hong Kong, consisting of 4,461 solar panels, which has been put into operation at the new Yuen Long plant. It is expected to produce 2,040,831 kwh of electricity per year, equivalent to the yearly electricity consumption of approximately 620 typical three-person households. In addition to providing clean and renewable energy for facilities, it also reduces greenhouse gases and pollutants released by traditional fossil fuel power generation.
Sustainable development is the vision of Fortune Pharmacal. We cannot operate with commercial interests alone. We actively promote renewable energy and conduct carbon audits to assess the product life cycle and measure the carbon footprint of the company's overall operations and supply chain. The results are used to formulate effective carbon reduction plans. Fortune Pharmacal has now passed the international carbon footprint calculation standard and obtained the globally recognized Carbon Trust certification. We hope to play a leading role in encouraging more companies to invest in sustainable development to care for the environment and take necessary actions to reduce their carbon footprint, and take a step further for future generations.
Please refer to Fortune Pharmacal Company Ltd’s website: www.fortunepharm.com , for more information.